×
0.0140845070422536 0.0281690140845071 0.0375586854460094 0.0281690140845071 0.0140845070422536 0.0610328638497654 -0.0340375586854459 -0.053943661971831
Stockreport

Capricor nabs accelerated review status in U.S. for Duchenne candidate CAP-1002; shares up 9% premarket [Seeking Alpha]

Capricor Therapeutics, Inc (CAPR)  More Company Research Source: Seeking Alpha
Last capricor therapeutics, inc earnings: 11/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Capricor nabs accelerated review status in U.S. for Duchenne candidate CAP-1002; shares up 9% premarketCapricor Therapeutics (NASDAQ:CAPR) is up9% premarket on modestly higher volume in response to itsannouncement that the FDA has designated Duchenne muscular dystrophy (DMD) candidate CAP-1002 a Regenerative Medicine Advanced Therapy (RMAT).RMAT is the same as Breakthrough Therapy status for drugs. It provides for more frequent interactions with the FDA, priority review and accelerated approval.A registration study, HOPE-2, is about to start enrollment.CAP-1002 is an investigational allogeneic, off-the-shelf cardiac cell therapy derived from donor heart tissue and infused directly into the patient's coronary artery via a catheter.See all stocks on the move »Now read:Teva: Is This What A Bloodbath Looks Like? » [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CAPR alerts

from News Quantified
Opt-in for
CAPR alerts

from News Quantified